Released 2024; approximately 380 reviews accumulated.
Verdicts
How well it fits each concern
Verdict by concern tap a concern for the case
Good choicefor HyperpigmentationIn your profileYou chose · Niacinamide is a trial-supported active for hyperpigmentation; this serum carries it at 10%.Moderate evidenceGentleNo reviews collected yet
The case for it
Niacinamide has trial-supported standing for this concern.
It is present at an effective concentration, declared or high in the ingredient list.
The formula carries none of the triggers this concern is sensitive to.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them.
Unchanged since September 5, 2026, engine 5.1.1.
Promisingfor DullnessIn your profileYou chose · Hyaluronic Acid has trial-level evidence for dullness but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceGentleNo reviews collected yet
The case for it
Multi-Form Hyaluronic Acid + Squalane has trial-level evidence for this concern but no guideline or regulatory standing yet.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them.
Unchanged since September 5, 2026, engine 5.1.1.
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Multi-Form Hyaluronic Acid + Squalane
Standing
plausible — trials support it
Form
plausible
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
Promisingfor Excess OilinessIn your profileYou chose · Niacinamide has trial-level evidence for excess oiliness but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet
The case for it
Niacinamide has trial-level evidence for this concern but no guideline or regulatory standing yet.
It is present at an effective concentration, declared or high in the ingredient list.
The formula carries no trigger this concern is sensitive to, with the cautions noted.
Cautions: fungal-acne triggers.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them.
Unchanged since September 5, 2026, engine 5.1.1.
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
adequate (declared 10%) — studied range 2%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard — fungal triggers
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
Promisingfor Dark SpotsIn your profileYou chose · Niacinamide has trial-level evidence for dark spots but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceGentleNo reviews collected yet
The case for it
Niacinamide has trial-level evidence for this concern but no guideline or regulatory standing yet.
It is present at an effective concentration, declared or high in the ingredient list.
The formula carries none of the triggers this concern is sensitive to.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them.
Unchanged since September 5, 2026, engine 5.1.1.
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
adequate (declared 10%)
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
Promisingfor Large PoresIn your profileYou chose · Niacinamide has trial-level evidence for large pores but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceGentleNo reviews collected yet
The case for it
Niacinamide has trial-level evidence for this concern but no guideline or regulatory standing yet.
It is present at an effective concentration, declared or high in the ingredient list.
The formula carries none of the triggers this concern is sensitive to.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them.
Unchanged since September 5, 2026, engine 5.1.1.
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
adequate (declared 10%) — studied range 4%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
Good choicefor MelasmaIn your profileYou chose · Tranexamic Acid is a trial-supported active for melasma; this serum carries it, though the concentration is not declared.Strong evidenceGentleNo reviews collected yet
The case for it
Tranexamic Acid has trial-supported standing for this concern.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them.
Unchanged since September 5, 2026, engine 5.1.1.
Where our review and the verdict differ. The review below was written on the formulation and the published trials; the verdicts above apply the stricter standing test in our methodology — an active earns a recommendation only with guideline or regulatory standing for the concern. Where the two disagree, the verdict is DermApproved’s position.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in.
Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
✗ 10% niacinamide may cause flushing in sensitive users
✗ Smaller 40ml format depletes faster than larger alternatives
✗ Multi-active complexity may exceed needs of users seeking simple brightening
Review
Full Review
Twenty-percent niacinamide serums made a splash a few years back on the seductive logic that more must mean more, and a lot of people learned the hard way that their skin disagreed, flushing and tingling its way through a bottle it never asked for. Jumiso's Niacinamide 10 percent Serum is the sensible correction to that maximalism: a concentration high enough to do serious brightening work, low enough to stay comfortable for most skin, and surrounded by a genuinely well-chosen committee of supporting actives rather than left to fend for itself in an otherwise empty base. It is, quietly, the version most people chasing a brightening serum actually want, and its strong scores reflect that balance rather than any single gimmick or headline percentage.
The formula is multi-pathway and built with more thought than its accessible price would lead you to expect. Ten percent niacinamide leads from the second INCI position, sitting in the upper effective range for tone-evening, barrier support, and sebum modulation while staying far more tolerable than the high-dose formulas, even if it can still cause flushing in the most reactive users. Joining it are tranexamic acid, glutathione, and hexylresorcinol, a trio of well-regarded brighteners that attack hyperpigmentation through complementary mechanisms rather than all piling onto the same one. Tranexamic acid is a documented melanin-synthesis inhibitor, glutathione brings its master-antioxidant credentials, and hexylresorcinol works on tyrosinase, the enzyme central to pigment production. Seeing that kind of multi-mechanism layering at this price point is genuinely unusual. Centella active fractions, the asiaticoside, madecassic-acid, and asiatic-acid kind, plus zinc PCA add real soothing and sebum control that buffer the higher niacinamide concentration and keep the formula comfortable. A multi-form hyaluronic acid paired with skin-mimetic squalane handles the hydration the brightening chemistry needs to avoid feeling drying. It is fragrance-free, oil-free, vegan, fungal-acne-safe, and pregnancy-safe, which is an unusually clean compatibility profile for something doing this much work.
Worn day to day, it is a lightweight serum that absorbs cleanly and layers without pilling under moisturizer and sunscreen, an easy daily step for chipping away at uneven tone, dullness, and stubborn dark spots. The sober read is that the brightening and tone-evening build gradually, with visible brightening over roughly 4 to 6 weeks and dark-spot fading over 8 to 12, because niacinamide and its supporting brighteners work cumulatively and reward consistency rather than intensity. Pairing it with diligent daytime sunscreen is what makes the whole effort actually pay off, since any pigment progress undone by daily UV exposure is wasted progress. Its real strength is being a comprehensive yet tolerable brightening serum that most skin can fold in without the cautious, fortnight-long ramp-up a higher-percentage formula demands. The limitations are minor and worth stating plainly: the 10 percent dose can still flush genuinely sensitive users, the 40ml format depletes faster than the larger bottles some brands offer, and the sheer number of actives is honestly more than someone who just wants a simple single-active brightener really needs.
Dollar for dollar this is excellent, and the value-for-money mark is the highest on the card for good reason. A ten-percent niacinamide serum carrying tranexamic acid, glutathione, hexylresorcinol, centella, and zinc PCA, all fragrance-free and fungal-acne-safe, at 24 dollars for 40ml is a remarkable amount of multi-mechanism brightening for the money, the sort of formula that would cost roughly double under a prestige label with a fraction of the active roster. Jumiso itself is an emerging K-beauty brand, founded in 2018 with a focus on sensitive-skin and accessible multi-active formulas, and this 2024 release sits squarely inside that mission. The medium data confidence simply reflects how recently it launched and a modest review count rather than any doubt about the well-studied individual actives. It is worth pausing on the one strategic question this serum raises, which is whether the multi-active approach is genuinely better than a simple single-ingredient brightener or just better-marketed. The fair answer is that it depends on your skin and your patience. Hyperpigmentation is stubborn precisely because it stems from several overlapping mechanisms, and hitting tyrosinase, melanin synthesis, and oxidative stress from different angles at once is, in principle, a more thorough strategy than relying on one pathway alone. The practical catch is that none of these actives is dosed at a heroic concentration, so the formula trades peak potency in any one direction for breadth across several, which is a reasonable bet for everyday maintenance and tone-evening but not the choice for someone wanting to bulldoze a specific dark spot as fast as possible. This is a fit for combination, oily, and normal skin dealing with uneven tone, dark spots, or dullness who want something effective but tolerable for daily use, and the gentle, fungal-acne-safe profile widens that to congestion-prone and mildly sensitive skin as well. For most people it is the genuinely smarter pick than reaching straight for a 20 percent formula. Avoid it if you have very dry skin that needs more emollient support than a lightweight serum can provide, if you genuinely react to niacinamide even at moderate doses, or if you specifically want one high-strength active rather than a thoughtful blend of several. But as a well-balanced, affordable, broadly usable brightening serum, it is one of the better everyday options on the shelf, and the kind of quiet overachiever that makes the maximalist 20 percent formulas look slightly reckless by comparison.
Formula
Key Ingredients
The hero actives that drive this product's performance.
Second INCI position at 10% concentration — upper effective range for brightening, barrier support, and sebum modulation. May cause flushing in sensitive users.
Melanin synthesis inhibitor with documented brightening efficacy. Combined with niacinamide and other brightening actives for multi-mechanism pigmentation chemistry.
Multi-mechanism brightening combinations with niacinamide, tranexamic acid, glutathione, and hexylresorcinol leverage different tyrosinase inhibition and melanin pathway interruption mechanisms. Published research supports each individual active. The combined formulation represents sophisticated K-beauty multi-active design.
References
Tranexamic acid in pigmentation treatment — Journal of the American Academy of Dermatology (2019)
Hexylresorcinol in brightening applications — Journal of Drugs in Dermatology (2015)
Dermatologist Perspective
Multi-active brightening serums are commonly recommended in dermatology for patients with hyperpigmentation or melasma concerns. The Jumiso formulation provides comprehensive chemistry at accessible price.
Guidance
Usage & Recommendations
How to Use
Apply 3-4 drops after toner in AM and PM. Always SPF in AM. Patch test for first use if sensitive to high niacinamide.
Value Assessment
At $24 for 40ml ($17.75 per ounce), the serum offers exceptional value within K-beauty multi-active brightening category.
Released 2024 as part of Jumiso's brightening serum line.
About Jumiso Established Brand (5–20 years)
Jumiso is a K-beauty brand founded in 2018 focused on sensitive-skin and accessible multi-active formulations. The Niacinamide 10% Serum combines 10% niacinamide with tranexamic acid, glutathione, hexylresorcinol, centella active fractions, and zinc PCA in comprehensive brightening chemistry at accessible pricing.
Brand founded: 2016 · Product launched: 2024
Myth vs. Reality
Common Myths
Myth
Higher niacinamide is always better.
Reality
Niacinamide benefits plateau above 5%, with 10% providing modestly better brightening at increased flushing risk. The Jumiso formulation's value is in the multi-active combination (niacinamide + tranexamic acid + glutathione + hexylresorcinol) more than the high niacinamide concentration alone.
FAQ
Frequently Asked Questions
How does this compare to The Ordinary Niacinamide 10% + Zinc 1%?
The Ordinary uses 10% niacinamide + zinc PCA simple base. Jumiso adds tranexamic acid, glutathione, hexylresorcinol, centella, and multi-form HA — significantly more comprehensive multi-mechanism brightening. Jumiso costs more but offers more sophisticated chemistry.
Is the Niacinamide 10% Serum safe to use during pregnancy?
Yes — niacinamide, tranexamic acid, glutathione all pregnancy-compatible.
Is this fungal-acne safe?
Yes — oil-free formulation.
Will the 40ml bottle last?
About 2 months at twice-daily face use.
Niacinamide flushing concern?
10% may cause initial flushing for some users — patch test. Centella buffering may reduce this.
How long until results?
Visible brightening over 4-6 weeks; dark spot fading over 8-12 weeks.
Reviews
What Reviewers Tend to Say
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
More products claim to fix dullness than any other concern, which is a strong hint the word means nothing — it is at least four separate mechanisms, and the one nobody sells for is the blood.
It was invented to stop bleeding during surgery. In 2026 it's in dozens of brightening serums — and the evidence is better than most trend ingredients can claim.
Japan runs a third regulatory tier between cosmetic and pharmaceutical, and once you can see it, the entire J-beauty aisle stops looking modest and starts looking legally precise.
Most heritage claims are unfalsifiable. This one sits on a public regulatory register — which makes it the rare case where you can check what 150 years of institutional research actually bought.
Aug 28, 2026· 7 min
Questions people ask about Hyperpigmentation
Verified answers from our questions library — the nuance a product page cannot carry.
Products, answers, therapy guides, tools and articles in one search. Brand names,
slang and abbreviations all work — accutane finds isotretinoin, bacne finds truncal acne.